Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing drospirenone and ethinylestradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely megestrol acetate 125 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing drospirenone and estradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone acetate 400mg/mL injection suspension 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Desogestrel 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norgestrel 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone acetate 150mg/mL injection suspension 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone acetate 400mg/mL injection suspension 2.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone 150mg/ml injection 1ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone acetate 400mg/mL injection suspension 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental progestogen poisoning |
Causative agent (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional progestogen poisoning |
Causative agent (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progestogen poisoning of undetermined intent |
Causative agent (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning caused by progestogen (disorder) |
Causative agent (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing estradiol and levonorgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydroxyprogesterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxyprogesterone hexanoate 250mg/1mL oily injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxyprogestérone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxyprogesterone hexanoate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gestonorone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 100mg vaginal insert |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing progesterone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to progesterone |
Causative agent (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Free progesterone |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone-releasing vaginal ring |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 200 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 200 mg oral capsule |
Has precise active ingredient |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely progesterone 100 milligram/2 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely progesterone 100 milligram/2 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely progesterone 50 milligram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely progesterone 50 milligram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing progesterone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only progesterone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 50 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 50 mg/mL solution for injection |
Has precise active ingredient |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 40 mg/g vaginal gel |
Has basis of strength substance (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 40 mg/g vaginal gel |
Has precise active ingredient |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 80 mg/g vaginal gel |
Has basis of strength substance (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 80 mg/g vaginal gel |
Has precise active ingredient |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 100 mg vaginal tablet |
Has precise active ingredient |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 100 mg vaginal tablet |
Has basis of strength substance (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Autoimmune progesterone dermatitis |
Causative agent (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 416.667 microgram/hour prolonged-release vaginal ring |
Has precise active ingredient |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone 416.667 microgram/hour prolonged-release vaginal ring |
Has basis of strength substance (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely progesterone 200 milligram/1 each conventional release vaginal capsule (clinical drug) |
Has precise active ingredient |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely progesterone 200 milligram/1 each conventional release vaginal capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum progesterone measurement |
Component |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Saliva 17alpha-hydroxyprogesterone measurement (procedure) |
Component |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |